home / stock / rnlx / rnlx quote
Last: | $0.802 |
---|---|
Change Percent: | 0.34% |
Open: | $0.782292 |
Close: | $0.802 |
High: | $0.81 |
Low: | $0.771 |
Volume: | 28,010 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.802 | $0.782292 | $0.802 | $0.81 | $0.771 | 28,010 | 04-19-2024 |
$0.784999 | $0.83 | $0.784999 | $0.83 | $0.73 | 209,438 | 04-18-2024 |
$0.83 | $0.8529 | $0.83 | $0.885 | $0.81 | 123,750 | 04-17-2024 |
$0.8245 | $0.84 | $0.8245 | $0.84 | $0.79 | 83,529 | 04-16-2024 |
$0.8426 | $0.91 | $0.8426 | $0.91 | $0.832 | 123,260 | 04-15-2024 |
$0.8929 | $0.9276 | $0.8929 | $0.94 | $0.87 | 90,347 | 04-12-2024 |
$0.928 | $0.8436 | $0.928 | $0.929 | $0.8289 | 291,978 | 04-11-2024 |
$0.8536 | $0.849 | $0.8536 | $0.86 | $0.811 | 54,457 | 04-10-2024 |
$0.849 | $0.8158 | $0.849 | $0.88 | $0.81 | 170,626 | 04-09-2024 |
$0.801 | $0.7857 | $0.801 | $0.8399 | $0.781 | 60,293 | 04-08-2024 |
$0.8 | $0.77 | $0.8 | $0.839 | $0.77 | 388,892 | 04-05-2024 |
$0.7836 | $0.8002 | $0.7836 | $0.83 | $0.77 | 177,760 | 04-04-2024 |
$0.8089 | $0.8 | $0.8089 | $0.858 | $0.7624 | 177,543 | 04-03-2024 |
$0.85 | $0.82 | $0.85 | $0.86 | $0.81 | 149,660 | 04-02-2024 |
$0.8253 | $0.87 | $0.8253 | $0.8789 | $0.8101 | 235,864 | 04-01-2024 |
$0.86 | $0.91 | $0.86 | $0.93 | $0.79 | 380,765 | 03-29-2024 |
$0.86 | $0.91 | $0.86 | $0.93 | $0.79 | 380,765 | 03-28-2024 |
$0.91 | $0.88 | $0.91 | $0.939 | $0.88 | 170,514 | 03-27-2024 |
$0.8836 | $0.9 | $0.8836 | $0.91 | $0.871 | 162,128 | 03-26-2024 |
$0.9066 | $0.95 | $0.9066 | $0.98 | $0.871101 | 418,300 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Renalytix AI plc Company Name:
RNLX Stock Symbol:
NASDAQ Market:
LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ:RNLX) (LSE: RENX) announces a registered direct offering of ...
LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “ Ordinary ...
LONDON and SALT LAKE CITY, March 14, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (Renalytix) announces that the KidneyIntelX In-Vitro Diagnostic test has been included in the final KDIGO (Kidney Disease Improving Global Outcomes) 2024 Clinical Practice Guideline for ...